Treatment of Primary Plasma Cell Leukemia with Carfilzomib and Lenalidomide-Based Therapy: Results of the First Interim Analysis of the Phase 2 EMN12/HOVON129 Study

Niels W C J van de Donk (Lecturer), Bronno van der Holt (Co-author), Fredrik H. Schjesvold (Co-author), Ka Lung Wu (Co-author), Stefano Spada (Co-author), Annemiek Broyl (Co-author), Wilfried Roeloffzen (Co-author), Alain Gaddiseur (Guest lecturer), Thomas Lund (Guest lecturer), Monique C Minnema (Guest lecturer), Massimo Offidani (Guest lecturer), Mariella Grasso (Guest lecturer), Andersen Niels Frost (Guest lecturer), Jo Caers (Guest lecturer), Benedetto Bruno (Guest lecturer), Sonja Zweegman (Guest lecturer), Pieter Sonneveld (Guest lecturer), Roman Hajek (Co-author), Reuben Benjamin (Co-author), Reuben Benjamin (Co-author), Francesca Gay (Co-author), Annette Juul Vangsted (Co-author), Pellegrino Musto (Co-author)

Activity: Talks and presentationsConference presentations

Period9. Dec 2019
Event typeConference
LocationOrlando, United States